Table 2.
Characteristics of included studies
| Author(s) (year), Location | Age of participants (year) | Groups (menstrual cycle phases) | Number of participants | Method of measurement | Results |
|---|---|---|---|---|---|
| Cook et al. (2000), USA [22] | 22–35 | F/O/L | 20 | ELISA | Significant difference among follicular (1.4 ± 0.9 ng/ml), ovulatory (1.7 ± 1.1 ng/ml) and luteal (1.4 ± 0.9 ng/ml) phases [p < 0.008] |
| Elder-Geva et al. (2005), Israel [17] | < 38 | F/L | 56 | IOT | No comparison between the phases |
| La Marca et al. (2006), Italy [23] | 18–24 | F/L | 12 | IOT | No significant difference between follicular (3.9 ± 1.3 ng/ml) and luteal (3.4 ± 1.1 ng/ml) phases [p > 0.05] |
| Elgindy et al. (2008), Egypt [24] | ≤ 37 | F/O/L | 33 | IOT | No significant difference among follicular (1.4 ± 1.1 ng/ml), ovulatory (1.43 ± 1.08 ng/ml) and luteal (1.35 ± 1.02 ng/ml) phases [p > 0.05] |
| Streuli et al. (2008), Switzerland [25] | 24.1 ± 3.5 | F/L | 10 | IOT | No significant difference between follicular (4.4 ± 1.2 ng/ml) and luteal (4.3 ± 2.29 ng/ml) phases [p > 0.05] |
| Robertson et al. (2011), Australia [26] | 21–35 | F/L | 18 | DSL | No significant difference between follicular (4.11 ± 2.49 ng/ml) and luteal (3.66 ± 2.43 ng/ml) phases [p > 0.05] |
| Deb et al. (2013), UK [27] | 18–35 | F/O/L | 35 | DSL | Significant difference among follicular (2.6 ± 1.39 ng/ml), ovulatory (2.61 ± 1.42 ng/ml) and luteal (2.92 ± 1.66 ng/ml) phases [p = 0.041] |
| Kissell et al. (2014), USA [20] | 18–44 | F/O/L | 259 | Gen II |
Significant difference between follicular (2.05 ± 2.09 ng/ml) and ovulatory phases (1.79 ± 1.08 ng/ml) [p < 0.01] Significant difference between ovulatory (1.79 ± 1.08 ng/ml) and luteal phases (1.93 ± 1.84 ng/ml) [p = 0.01] Significant difference between follicular (2.05 ± 2.09 ng/ml) and luteal phases (1.93 ± 1.84 ng/ml) [p = 0.05] |
| Pankhurst et al. (2016), New Zealand [21] | 18–30 | F/O/L | 11 | Gen II | No significant difference among follicular (6.412 ± 3.7 ng/ml), ovulatory (6.2 ± 2.96 ng/ml) and luteal (5.8 ± 2.83 ng/ml) phases [p > 0.05] |
| Melado et al. (2018), Spain [28] | 18–38 | F/O/L | 22 | Elecsys® AMH automated assay (Roche®) | Significant difference among follicular (2.93 ± 1.74 ng/ml), ovulatory (2.91 ± 1.82 ng/ml) and luteal (2.95 ± 1.61 ng/ml) phases [p < 0.05] |
| Gorkem et al. (2019), Turkey [29] | 18–38 | F/L | 257 | Gen II | Significant difference between follicular (4.3 ± 3.9 ng/ml) and luteal phases (3.5 ± 3.1 ng/ml) [p < 0.001] |
F follicular, O ovulatory, L luteal